Over the last three years I've watched this stock, it's not easy to predict events. Stock price, a little bit more so... it was relatively easy to see the recent bottom, or at least feel confident that acquiring more in the 1.50's was likely a good buy. I look forward to when the predictability ends and I think that is going to occur as we get closer to the Brilacidin trial completion. There is no reason to think some big moves are not in our (relatively) near future. I'm all in till then, I'm sitting at my peak share count right now. It's not because I thing something like fasttrack is about to happen, it's because the fundamentals and trial progression continue to advance into a position of more strength and less risk.